People · Operator
Named in public records as an officer, director or promoter · active 2008–2023 · Other, Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Revascular Therapeutics Inc | — | Other | Series A | $25.8M | $109.5M | 2008 |
| ProMed Inc | — | Other Health Care | Series A | $21.9M | $30.3M | 2009 |
| Payground, Inc. | — | Other Technology | Series B | $19.8M | $217.2M | 2023 |
| Generic Medical Devices Inc | — | Other | Series A | $16.9M | $13.7M | 2010 |
| Ovalis Inc | — | Other Health Care | Seed | $3.1M | $12.2M | 2009 |
| Fliqz Inc | — | Other Technology | Seed | $1.0M | $34.1M | 2009 |
Peter Fitzgerald at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter Fitzgerald on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steve Salmon | 4 | 6 |
| Richard Ferrari | 3 | 15 |
| David Mauney | 2 | 10 |
| Richard Ginn | 2 | 3 |
| Ronald Jabba | 2 | 2 |
| Todd Johnson | 1 | 27 |
| David White | 1 | 11 |
| DANIEL JOHNSON | 1 | 5 |
| David Schulte | 1 | 4 |
| Carl Simpson | 1 | 4 |
| A. Barr Dolan | 1 | 3 |
| Michael Lynn | 1 | 3 |
| Bruce J Brumfield | 1 | 3 |
| Robert Cummins | 1 | 2 |
| Stephen M. Salmon | 1 | 2 |
| Richard P. Kuntz | 1 | 2 |
| Andrew Mercer | 1 | 2 |
| Pamela B. Westbrook | 1 | 2 |
| Tom Palermo | 1 | 1 |
| David R. Schulte | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.